Quick Takeaways
- FRANKLIN RESOURCES INC filed SCHEDULE 13G/A for EyePoint Pharmaceuticals, Inc. Common Stock, par value $0.001 (EYPT).
- Disclosed ownership: 7.5%.
- Date of event: 30 Sep 2024.
Quoteable Key Fact
"FRANKLIN RESOURCES INC disclosed 7.5% ownership in EyePoint Pharmaceuticals, Inc. Common Stock, par value $0.001 (EYPT) on 30 Sep 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Franklin Resources, Inc. | 7.5% | 4,012,048 | 4,012,048 | 0 | /s/Thomas C. Mandia | Thomas C. Mandia, Assistant Secretary of Franklin Resources, Inc. | |
| Charles B. Johnson | 0% | 0 | 0 | 0 | /s/Thomas C. Mandia | Attorney in Fact for Charles B. Johnson pursuant to Power of Attorney attached to this Schedule 13G | |
| Rupert H. Johnson, Jr. | 0% | 0 | 0 | 0 | /s/Thomas C. Mandia | Attorney in Fact for Rupert H. Johnson, Jr. pursuant to Power of Attorney attached to this Schedule 13G | |
| Franklin Advisers, Inc. | 7.4% | 3,983,714 | 3,983,714 | 0 | /s/Thomas C. Mandia | Thomas C. Mandia, Assistant Secretary of Franklin Advisers, Inc. |